My major research interest is in radiation therapy for lymphomas, genitourinary cancers—including prostate cancer, bladder cancer and seminoma—and late effects of treatment, especially second cancers. Current research activities include study of image guided precision radiotherapy. I also have a long-standing interest in cancer classification with an emphasis on staging and prognostic factors. In addition, my current interests include the application of modern information and communication technologies in cancer control.
Mary K Gospodarowicz
Role of salvage radiation therapy for patients with relapsed or refractory hodgkin lymphoma who failed autologous stem cell transplant.
Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e329-35
A one-step cone-beam CT-enabled planning-to-treatment model for palliative radiotherapy-from development to implementation.
Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):834-40
Excellence in Radiation Research for the 21st Century (EIRR21): description of an innovative research training program.
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e563-70
Cancer. 2012 Nov 1;118(21):5245-50
CMAJ. 2012 Oct 16;184(15):1699-704
Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer.
Clin Cancer Res. 2012 Apr 1;18(7):2108-14
Testicular cancer survivors' supportive care needs and use of online support: a cross-sectional survey.
Support Care Cancer. 2012 Nov;20(11):2737-46
N Engl J Med. 2012 Feb 2;366(5):399-408
Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.
Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):608-16
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.
Lancet. 2011 Dec 17;378(9809):2104-11
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto
President, Union for International Cancer Control (UICC)